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Introduction: Since the 1980s, leeches have been ingeniously used in the management of venous flap congestion.
The presence of anticoagulative substances in their saliva improves the blood drainage. Their digestive tract
contains several bacterial species, the main ones being Aeromonas hydrophila and Aeromonas veronii biovar sobria,
which contribute to the digestion of ingested blood. These bacteria can be the cause of infections.
Case presentation: We report two cases of septicemia related to Aeromonas veronii biovar sobria that presented
after leeches had been applied to congested transverse rectus abdominis myocutaneous flaps for delayed
mammary reconstructions.
Patient number 1 was a 55-year-old Caucasian woman who underwent a delayed breast reconstruction procedure.
On the sixth postoperative day she showed a clinical presentation of septicemia. Aeromonas veronii biovar sobria
was identified in the patient’s skin and blood bacteriological samples. Her fever ceased after 4 days of antibiotic
treatment.
Patient number 2 was a 56-year-old Caucasian woman who underwent a delayed breast reconstruction procedure.
On the seventh postoperative day we noticed that she showed a clinical presentation of septicemia. Aeromonas
veronii biovar sobria was identified in the patient’s blood cultures and local bacteriological samples. An antibiogram
showed resistance to amoxicillin/clavulanic acid. Her fever ceased on the eleventh postoperative day after 4 days of
antibiotic treatment.
Conclusion: The rate of infection after application of leeches is not negligible. The concentration of Aeromonas
inside the digestive tracts of leeches largely decreases when the patient is under antibiotic therapy. These germs
are sensitive to third-generation cephalosporins and fluoroquinolones and resistant to amoxicillin/clavulanic acid.
We recommend preventive treatment based on classical measures of asepsis and on oral antibioprophylaxy with a
fluoroquinolone during the whole period of treatment by leeches.
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Leeches have been used for therapeutic purposes since
3500 B.C. Their qualities were discovered in former
Egypt, China and India. A mural painting representing a
nurse applying a leech to a patient’s forehead was dis-
covered in a grave in Thebes (origin of the pharaohs of
the 18th dynasty). The first written reference goes back
to the second century B.C. and deals with the treatment
of poisonous bites. The use of leeches reached a peak in
the nineteenth century for various indications: laryngitis,* Correspondence: ben.maetz@wanadoo.fr
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reproduction in any medium, provided the orophthalmic problems, cerebral apoplexy, obesity, and
mental disorders. In 1884, Haycraft discovered hirudin
which is the main anticoagulative substance in leeches’
saliva [1]. In 1955, Markwardt was the first to isolate
hirudin from the pharyngeal glands of leeches. Nowadays,
this substance is only produced by genetic engineering. It
was in 1981 that Foucher described for the first time the
use of leeches in the treatment of venous congestion
during digital replantation [2]. Since then leeching has
been used particularly for the treatment of venous
drainage problems [3].
Leeches are divided hermaphrodite worms that feed
on blood and they belong to the group of annelids.
Many species are known and the two most commonlytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and Hirudo verbana [4]. Their length is about 12cm and
their weight is 2g to 5g. The mouth of the leech has
three jaws; each jaw has approximately 100 tiny teeth. A
leech also has a posterior suction device that it uses for
stability. Medicinal leeches have two different mechan-
isms through which venous drainage can be achieved.
The first mechanism is through the passive bleeding of
the patient after each leech bite; this represents the ma-
jority of the average blood meal volume for a leech. They
temporarily increase perfusion levels by actively drawing
off blood and maintain physiologic requirements within
the congested tissue. Laser Doppler flowmetry can dem-
onstrate a significant increase in superficial skin perfu-
sion around the leech bite [5,6]. Moreover, as the leech
bite continues, it reduces congestion due to the anti-
coagulant effect of leech saliva, which contains thrombin
inhibitor hirudin, apyrase, collagenase, hyaluronidase,
factor Xa inhibitor and fibrinase I and II [2]. A leech
consumes 5mL to 15mL of blood and induces oozing on
the site of attachment of between 50mL and 100mL of
blood during the 24-hour to 48-hour period after the
leech is detached.
In clinical practice, the area that needs to be treated
has to be cleaned with an antiseptic solution then with
physiological serum because the leeches are very sensi-
tive to odors [7]. During the process, leeches are handled
with gloves. If the leech does not stick to the right place,
then the leech has to be moved to the right area. When
the leeches have ingested enough blood, they will fall
away by themselves. Removing the leeches by hand can
cause small phlegmons which are sources of infection.
Leeches are applied once or twice a day until capillary
circulation is restored (4 or 5 days; Figure 1).
In France, medicinal leeches are supplied by Ricarim-
pexW. Before being used, leeches are kept in a bowl ofFigure 1 Venous congestion treated by leeches.sterile water under refrigeration. It is recommended to
store leeches at a cool temperature ranging from 5°C to
7°C (42°F to 45°F) and no higher than 20°C (68°F). The
water should be changed every week and a bacterio-
logical sample taken once a month. Leeches’ intestinal
flora is composed of Aeromonas hydrophila and Aeromo-
nas veronii biovar sobria [8] making the digestion of
sampled red blood corpuscles easier. Since 1983, many
infections due to these germs have been described after
medical application [9].
We report two cases of septicemia related to A. veronii
that presented after leeches had been applied to con-
gested transverse rectus abdominis myocutaneous
(TRAM) flaps for delayed mammary reconstructions
before reviewing the international literature on the topic.
Case presentation
Patient number 1
The first patient was a 55-year-old Caucasian woman
who underwent a mastectomy for a breast cancer fol-
lowed by radiotherapy and chemotherapy. Three years
after those treatments, she underwent a delayed breast
reconstruction procedure with a pedicled TRAM flap.
Due to a massive and immediate venous congestion,
she had to undergo 12 hours later a second operation
and the flap had to be moved back to the initial position.
Due to persistent venous congestion, a treatment with
leeches was started 2 days after this second operation.
Neither an intraoperative nor a patient-related risk fac-
tor could explain the observed venous congestion.
On the sixth postoperative day, following 4 days of
leeching, the vascular status of the flap improved, but
the patient showed a clinical presentation of septicemia
associated with 39.2°C hyperthermia, a white blood cell
count of 27,44 109/L and a C-reactive protein (CRP)
level increased by 153mg/L.
While blood cultures and local bacteriological swabs
were being analyzed, an intravenous antibiotic therapy
was started including vancomycin (1.5g/day) and cefo-
taxime (6g/day) for 10 days, and amikacin (350mg/day)
for 2 days.
A. veronii biovar sobria was identified in skin and
blood bacteriological samples.
The fever ceased after 4 days of antibiotic treatment.
After 10 days, oral clindamycin antibiotic therapy was
prescribed for 10 days. The flap was moved back to the
mammary position at day 12 after 48 hours of apyrexia.
The patient left the hospital at day 19.
Patient number 2
The second patient was a 56-year-old Caucasian woman
who underwent a mastectomy for a relapse after a first
breast cancer treated by tumorectomy followed by radio-
therapy. Despite the possibilities of immediate breast
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Ten months later, she was motivated for a delayed pro-
cedure. Because we were not used to performing deep
inferior epigastric perforator flaps at that time, she had a
breast reconstruction using a pedicled TRAM flap.
Despite the absence of intraoperative complications
and patient-related risk factors, the flap presented an
early venous congestion that was treated from the sec-
ond to the fifth postoperative day by leeching and
heparin-moist gauzes. A partial necrosis settled in the
mammary and abdominal area.
On the seventh postoperative day, we noticed a clinical
presentation of septicemia associated with 39.8°C hyper-
thermia, a white blood cell count of 15 × 109/L and a
CRP level increased by 114mg/L.
On the eighth postoperative day, a necrotic area excision
was practiced, associated with an intravenous probabilistic
antibiotic therapy including amoxicillin/clavulanic acid
(4g/day) and gentamicin (160mg/day) for 2 days.
A. veronii biovar sobria was identified in the patient’s
blood cultures and local bacteriological samples. An
antibiogram showed resistance to amoxicillin/clavulanic
acid, which was stopped at day 10 and replaced by cefo-
taxime (6g/day) for 10 days followed by oral ofloxacin
(400mg/day) for eight days. The fever ceased on the
eleventh postoperative day after four days of antibiotic
treatment. She left the hospital at day 20.
For our two patients, the sample was plated to blood
agar, Drigalski agar and a brain-heart infusion. The iso-
late was identified by using a Vitek 2 Gram-negative card
(bioMérieux Inc., Marcy L’étoile, France). Antimicrobial
susceptibility was tested by using a 24-hour disk-diffu-
sion method on Mueller-Hinton agar plates incubated at
37°C in an ambient air incubator.
Discussion
Similar cases of infections due to leeching on TRAM flaps
have been described in the literature [10]. It was in 1983
that Whitlock et al. suggested for the first time that there
could be a risk of infection by A. hydrophila attached to
leeching. Whitlock showed the presence of A. hydrophila
on the leech’s body by making bacteriological samples.
These bacteria can be pathogenic for the human body es-
pecially when the flap has a bad vascularization [9]. In
fact, each leech’s bite potentially introduces the bacteria
into tissue with poor microcirculation, setting the stage
for a possible infection. In the literature, many cases of in-
fection after leeching have been described [11]: 18 cases in
1992 by Lineaweaver [12], 19 cases in 1996 by De Chalain
[13], 7 cases in 2002 by Sartor [14], and 47 cases in 2007
by Bauters [15]. The rate of infection can be important
varying from 2.4% to 20.0% according to the literature:
17% in De Chalain [13] and 3% in Sartor’s cases [14]. De
Chalain et al. [13] described 19 cases of leeche-relatedAeromonas infection. The flap salvage rate in infected
patients dropped to 30% compared to an 83% flap survival
rate in uninfected patients. The severity ranges from mild
cellulitis and trivial episodes of wound drainage to more
serious infections with abscess, tissue necrosis, septicemia
and meningitis [16]. Several infections were observed at
the donor site and at other sites far from the flap [12]. Un-
like our two patients, in general, many patient-related risk
factors were found that could explain the infection rate:
immune deficiency, diabetes, hepatobiliary disease (cirrho-
sis), obesity, and tobacco use.
Infection starts most of the time during the first 10
days, but in some cases infection can appear a few weeks
after leeching [16]. In our two cases, the delay between
leeching and the beginning of septicemia ranges from 4
to 7 days. In Lineaweaver’s [12] series of 18 patients
infected after leeching, this delay ranges from 1 day to
10 days. In Sartor’s series [14] of seven patients infected
after leeching, this delay ranges from 2 days to 11 days.
Numerous germs have been identified from leeches [17].
The saliva from H. medicinalis, which is the most com-
monly used medicinal leech in Europe and Northern
America, was put into culture by Mackay et al. and they
showed the presence of A. hydrophila and Aeromonas
sobria [18]. The most common germ is A. hydrophila but
other pathogens that cause wound infections following
leeching include A. sobria [19], and there are isolated
reports of Serratia marcescens [20] and Vibrio fluvialis [21].
A. veronii biovar sobria was found in blood cultures as well
as in local bacteriological samples of our two patients.
The Aeromonas produces a β-lactamase that induces a
resistance to penicillin and first-generation cephalospor-
ins [22]. This resistance is confirmed on the antibiogram
of our two patients (Table 1). The antibiotic therapy
using amoxicillin/clavulanic acid prescribed to the sec-
ond patient was not efficient. Yet, as mentioned by Her-
mansdorfer [23], the third-generation cephalosporins,
ciprofloxacin and aminosids are efficient on Aeromonas.
Our two patients did not receive the same antibiotics be-
cause they were treated in two different hospitals of the
same area. For the first patient the antibiotic therapy
was quickly effective whereas for the second patient the
antibiotic therapy became active only after associating
cefotaxime to aminosids. The symptoms of our two
patients disappeared after 4 days of antibiotherapy.
Before use and in order to avoid human infection, some
authors propose immersing leeches in a solution of anti-
biotics for a few days or in a solution of chlorhexidine at
1:5000 before therapeutic use. Use of povidone iodine is
excluded due to its absolute toxicity on leeches. Hokelek
et al. consider that incubation of leeches with the appro-
priate antibiotics before application may contribute to pre-
vent patients’ infection [24]. Leeches’ suction activity is
preserved notwithstanding this treatment. Different
Table 1 Patients’ antibiogram
Antibiotic Patient 1 Patient 2
Amoxicillin R R
Amoxicillin/clavulanic acid R R
Piperacillin S S
Tazocillin S S
Cefalotin R S
Cefotetan S
Cefotaxime S S
Ceftazidim S S
Cefepim S
Imipenem S S
Aztreonam S S
Gentamicin S S
Tobramycin S S
Amikacin S S
Isepamicin S
Ofloxacin S S
Ciprofloxacin S S
Trimethoprim/Sulfamethoxazole S S
R: Resistant, S: Sensitive.
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efficiency and their impact on bacterial concentration in-
side the leeches’ digestive tract was studied. The results
showed that optimum eradication of bacteria from leeches
was obtained with a dosage of 500μg per mL of ciprofloxa-
cin and 1000μg per mL of ceftriaxone. Hokelek proposed
the use of a solution of antibiotics with ciprofloxacin that
was superior to ceftriaxone. Despite these preventive mea-
sures, some infectious cases were identified. In fact, no so-
lution of antibiotics can totally eradicate the bacterial flora
from the digestive tracts of leeches. Lineaweaver [25]
nevertheless noticed an important decrease in the concen-
tration of bacteria inside the digestive tracts of leeches
when the patient is under an effective antibiotic therapy.
Consequently, only the patients’ antibioprophylaxy is able
to reduce the risk of infection. In 2002, Chepeha et al.
[26] used double coverage with ciprofloxacin and tri-
methoprim/sulfamethoxazole prophylaxis in eight patients
treated for venous congestion with an average of 215
leeches per patient without any Aeromonas infection
reported. In 2004, Whitaker et al. [27] proposed a prophy-
lactic protocol for the patient based on an intravenous
antibioprophylaxy associating a fluoroquinolone such as
ciprofloxacin and an aminosid during the complete period
of leeching. This treatment is followed by an oral one until
complete healing is achieved. In 2007, Knobloch et al. [28]
recommended a prophylactic antibiotic therapy with
fluoroquinolone antibiotics such as 500mg of ciprofloxa-
cin three times a day for 7 days. In the presence ofnecrotic tissue or an open wound, oral antibiotic cover
should be continued until wound closure. Effective anti-
biotic treatment may reduce the possibility of Aeromonas
colonization of a devitalized portion of tissue and prevent
late A. hydrophila infection [29].
Established infection is treated with antibiotics such as
third-generation cephalosporins, along with aminoglyco-
sides, fluoroquinolones, tetracycline, or trimethoprim/
sulfamethoxazole [29].
As for our two patients, Hermansdorfer’s and Braga’s
studies reveal that the Aeromonas is sensitive to fluoro-
quinolone, particularly ofloxacin and ciprofloxacin [23,30].
Ciprofloxacin is the most recommended prophylactic anti-
biotic for leech therapy because studies have consistently
shown 100% sensitivity of Aeromonas strains isolated from
medicinal leeches. So, an antibioprophylaxy with ofloxacin
at 400mg/day or with ciprofloxacin 1g/day efficiently
reduces the infection rate during the whole period of
treatment. Tissue penetration is good and side effects are
limited. Ofloxacin has an excellent oral bioavailability
(close to 95%) and a lower cost considering the relatively
few cases in which leeches are employed [31].
In 2011, Wang et al. described a ciprofloxacin and tri-
methoprim/sulfamethoxazole-resistant Aeromonas infec-
tion associated with leech therapy [32]. Studies that
examined the antibiotic resistance profile of Aeromonas
strains in industrial fish farms found a resistance to
ciprofloxacin and to trimethoprim/sulfamethoxazole
estimated to be 3% and 1%, respectively [33,34]. Cur-
rently, ciprofloxacin and trimethoprim/sulfamethoxazole
resistances in Aeromonas are rare. In order to determine
appropriate antibiotic prophylaxis on local resistance
patterns, surgeons and infectious disease specialists have
to collaborate. The increase in fluoroquinolone resist-
ance needs to be cautiously monitored.
Conclusion
The rate of infection after leeching is not negligible. It var-
ies from 2.4% to 20.0% according to the literature [11,12].
The concentration of Aeromonas inside the digestive tracts
of leeches largely decreases when the patient is under anti-
biotic therapy. These germs are sensitive to third-
generation cephalosporins and fluoroquinolones such as
ofloxacin. We recommend preventive treatment based on
classical measures of asepsis and on oral antibioprophylaxy
with fluoroquinolones such as ofloxacin at 200mg twice a
day during the whole period of treatment by leeches.
Consent
Written informed consent was obtained from the two
patients for publication of these case reports and any ac-
companying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
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